MI Medicine International 2754-3242 2754-1304 D.A. Spandidos MI-4-4-00166 10.3892/mi.2024.166 Articles Awake craniotomy in patients with arteriovenous malformation: A systematic review and meta‑analysis HarikrishnaArya 1 * ChatzidakisStefanos 1 * IshakAngela 1 FaropoulosKonstantinos 2 FotakopoulosGeorge 3 GeorgakopoulouVasiliki Epameinondas 4 SklapaniPagona 5 TrakasNikolaos 5 YiallourisAndreas 1 IosifChristina 1 AgouridisAris P. 1 HadjigeorgiouGeorge 1 6 7 School of Medicine, European University Cyprus, 2404 Nicosia, Cyprus Department of Neurosurgery, Nicosia General Hospital, 2031 Nicosia, Cyprus Department of Neurosurgery, General University Hospital of Larissa, 41221 Larissa, Greece Department of Pathophysiology, National and Kapodistrian University of Athens, 11527 Athens, Greece Department of Biochemistry, Sismanogleio Hospital, 15126 Athens, Greece Department of Minimally Invasive Neurosurgery, Athens Medical Center, 14562 Athens, Greece Department of Neurosurgery, Apollonion Private Hospital, 2054 Nicosia, Cyprus Correspondence to: Dr George Fotakopoulos, Department of Neurosurgery, General University Hospital of Larissa, Mezourlo 1, 41221 Larissa, Greece gfotakop@yahoo.gr

*Contributed equally

 Jul-Aug 2024 06 06 2024 4 4 42 19 01 2024 22 05 2024 Copyright: © 2024 Harikrishna et al. 2024 This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.

The present systematic review aimed to identify all the available literature on awake craniotomy (AC) in patients with arteriovenous malformation (AVM) in order to evaluate its safety, risks, benefits and effectiveness. All available literature on AC in patients with AVM was collected and evaluated in an aim to provide a better understanding of its safety, associated risks and benefits. A systematic search for studies employing AC in patients with AVM was conducted using the PubMed, Scopus and ScienceDirect databases without restrictions on the year of publication, language, or study design, from inception up to May 30, 2021. A total of 11 studies published between 2004 and 2021 with 106 patients who underwent ACs were considered eligible. The rate of complete resection was 93% [95% confidence interval (CI), 82 to 100%; I2 0%]. The intraoperative complication rate was 21% (95% CI, 1 to 41%; I2 55%) and the post-operative complication rate was 33% (95% CI, 19 to 48%; I2 40%). During follow-up, the complication rate was 6% (95% CI, 1 to 10%; I2 30%). The post-operative complication rate was higher in the Spetzler-Martin grade (SMG) III-V group (31%; 95% CI, 21 to 42%; I2 46%) than in the SMG I-II group (12%; 95% CI, 2 to 22%; I2 0%). Similarly, the follow-up complication rate was higher in the SMG III-V group (9%; 95% CI, 2 to 16%; I2 34%) than in the SMG I-II group (0%; 95% CI, 0 to 4%; I2 0%). On the whole, the present study provides preliminary evidence to indicate that AC is a possible and useful option for the resection of AVM in selected patients. Well-designed future studies with long-term follow-up are required however, to investigate various aspects of safety and provide solid data for AC in patients with AVM.

 arteriovenous malformations awake craniotomy neurologic outcomes surgical resection Funding: No funding was received. Introduction

Cerebral vascular malformations present a range of lesions, among which arteriovenous malformation (AVM) is the most common (1). The management of AVM involves a multi-disciplinary approach and often requires a combination of treatments, including surgery, embolization and radiosurgery (RS) (2,3). The surgical removal of an arteriovenous malformation (AVM) can be challenging for any neurosurgeon (1,2). Depending on an the anatomic complexity, size and position of AVMs with regard to eloquent areas, a long surgical or a multidisciplinary team and numerous sessions may be required to achieve maximum resection (3). More specifically, the surgical maneuvers required for the resection of an AVM could jeopardize the neurological integrity of the patient, particularly if it is located in an eloquent area (4,5). AVMs are highly variable in size, shape and location. However, patterns emerge and subtypes with definable anatomy appear, enabling a certain degree of classification (3). The Spetzler-Martin grading (SMG) scale is the most commonly used classification method to describe AVMs. It considers the size of the AVM, the location of the nidus and the pattern of venous drainage (3). The development of brain mapping techniques, such as functional magnetic resonance imaging (fMRI), electrocorticography (ECoG), intracranial electroencephalography and electrical stimulation during awake craniotomy (AC) could aid in the modern neurosurgical treatment of AVMs in eloquent areas (3,6). As for the first choice, there is evidence to suggest that fMRI may not be helpful during the resection of AVMs in eloquent areas (6). To the best of our knowledge, this is the first meta-analysis to evaluate the role of AC in patients with AVM. The main aim of the present study was to assess the associated risks and benefits of AC in the resection of AVMs by recording all the neurological outcomes. The present also aimed to identify the rate of complete resection, intraoperative and post-operative complications, and subgroups of individuals who will benefit from AC.

 Data and methods <sec> <title>Search strategy

A systematic search and narrative literature review were undertaken, compatible with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines (7), as presented in Fig. 1. A comprehensive electronic bibliographic search was performed in order to identify articles published from database inception to May 30, 2021. The electronic databases of PubMed, Scopus and ScienceDirect were searched using a combination of the following terms as either key words or Medical Subject Headings (MeSH): (awake) AND [(craniotomy) OR (microsurgery) OR (surgery)] AND [(arteriovenous malformations) OR (intracranial arteriovenous malformations) OR (brain arteriovenous malformations) OR (AVM)]. No limitations as to the year of publication, or study design were applied. The complete search strategy used for PubMed was as follows: (awake) AND [‘craniotomy’ (MeSH)] OR [‘microsurgery’ (MeSH)] OR (surgery) AND [‘Arteriovenous Malformations’ (MeSH)] OR [‘Intracranial Arteriovenous Malformations’ (MeSH)] OR (brain arteriovenous malformations) OR (AVM).

The titles and abstracts of all the retrieved articles were screened and examined to determine their relevance. Articles with titles and abstracts that met the inclusion criteria (as described below) were selected for further review. In addition, the references to retrieved full-text articles were examined to identify potentially relevant articles that were not detected through the electronic search.

 Study selection and quality assessment

Two impartial reviewers (AH and SC) screened THE titles and abstracts found through the initial search strategy to determine eligibility. In the case that the title and abstract were unclear regarding the inclusion of a study, the full text was obtained and evaluated to determine its eligibility. Differences in study eligibility were resolved by engaging in discussions with a third reviewer (GH) to achieve consensus when necessary.

For case reports, the quality of the included studies was evaluated using the Appraisal Checklist for case reports proposed by The Joanna Briggs Institute (JBI) (8). The tool consisted of eight questions to assess different domains of the study (clear reports of patient demographics, patient history, clinical condition, diagnostic/assessment tests, intervention/treatment, post-intervention clinical condition, adverse events and important takeaway lessons). Each question was answered with ‘yes’, ‘no’, ‘unclear’, or ‘not applicable’. One point was allocated for each ‘yes’ answer and the total score ranged between 0 and 8. The studies were categorized as follows: i) Score of 0 to 1 point, low quality; ii) score of 2 to 4 points, moderate quality; and iii) score of 5 to 8 points, high quality.

For case series, the quality of the included studies was evaluated using the Appraisal Checklist for case series proposed by The JBI (8). The tool consisted of ten questions to assess different domains of the study (clear reports of inclusion criteria, standardized method of measuring, valid methods for identification of all participants, consecutive inclusion of patients, complete inclusion of patients, patient demographics, clinical information, follow-up results, present sites/clinics demographic information and appropriate statistical analysis). Each question was answered with ‘yes’, ‘no’ or ‘unclear’. One point was allocated for each ‘yes’ answer and the total score ranged between 0 and 10. The studies were categorized as follows: i) Score of 0 to 3 points, low quality; ii) score of 4 to 6 points, moderate quality; or iii) score of 7 to 10 points, high quality.

For cohort studies, the quality of the included studies was evaluated using the Appraisal Checklist for cohort studies proposed by The JBI (8). The tool consisted of 11 questions to assess different domains of the study (study groups similarity, similar measurements of exposure, valid and reliable measure of exposure, identification of confounders, strategies to minimize confounders, all participants free of outcome at the start of the study, valid and reliable measure of outcomes, sufficient follow-up period, follow-up complete in all participants, strategies to address incomplete follow-up and appropriate statistical analysis). Each question was answered with ‘yes’, ‘no’ or ‘unclear’. One point was allocated for each ‘yes’ answer and the total score ranged between 0 and 11. The studies were categorized as follows: i) Scored of 0 to 4 points, low quality; ii) score of 5 to 7 points, moderate quality; or iii) score of 8 to 11 points, high quality.

 Eligibility criteria

The articles were eligible for the systematic review if they: i) Included adult patients; ii) the patients included underwent AC for AVM resection; iii) had any outcomes reported during and following AC; iv) were primary research articles; and v) were published in the English language. All review articles, commentaries and editorials were excluded.

 Outcomes of interest

The primary outcome of interest was to assess the risk-benefit of AC in AVM resection by recording all the neurological outcomes (complete resection status, intraoperative complications and post-operative neurological deficits). The secondary objective was to evaluate the disparity in the frequency of post-operative complications and follow-up complications between SMG I-II and SMG III-V.

 Data extraction

Using an extraction form in an Excel® spreadsheet (Microsoft Corporation), AH and SC extracted the data. The data extracted included the following: Primary study author, year of publication, country, study design, population size undergoing AC, sex, mean age (in years), AVM location, hemorrhage or seizure at presentation, preoperative imaging, intraoperative neuromonitoring (IONM) method, SMG, follow-up duration (in months) and the aims of each study. Data on intraoperative complications, intraoperative airway difficulties or lack of cooperation, post-operative complications, postoperative neurological deficit, complete resection status and imaging outcomes were also extracted.

 Statistical analysis

Data processing and statistical analysis were stored and conducted on Microsoft Excel® and R-Studio version 2024.4.0.735, respectively (9). Overall proportion with their 95% confidence intervals (CIs) were calculated for the categorical variables. The heterogeneity between the included studies was evaluated with I2 and P-values. In the case of P>0.05 and/or I2≤50%, the difference in heterogeneity between studies was considered statistically insignificant; hence, the meta-analysis was performed using a fixed-effects model. On the contrary, in the case of P≤0.05 and/or I2>50% the statistical heterogeneity between studies was considered significant, and the meta-analysis was performed using a random-effects model. Finally, when sufficient outcomes were available, subgroup analyses of proportions were conducted, regardless of heterogeneity, in studies with specific outcomes for SMG I-II and SMG III-V.

 Results <sec> <title>Literature search results

Based on the search strategy, 1,261 titles and abstracts were retrieved (PubMed, 37; ScienceDirect, 1,181; Scopus, 43), and the subsequent screening process is presented in Fig. 1. Subsequently, 16 potentially relevant full-text articles were obtained for a detailed evaluation. In addition, two more potentially relevant articles were identified from the reference lists of the 16 full-text articles. Of note, four of the articles had missing information as regards the location, type, or treatment of the AVMs, and for another three articles, the retrieval of the full text was not achievable, despite multiple efforts being made; therefore, they were excluded. Of the 18 articles, 11 articles met the inclusion criteria and were selected for analysis in the present systematic review.

 Study and patient characteristics

A total of 11 studies with 106 patients who underwent AC were included in the present systematic review (1,4,10-18). More specifically, of the eligible studies included, six studies were conducted in the USA, two studies were conducted in China, and three studies were conducted in Japan, Pakistan, and Switzerland. The characteristics of the included studies are summarized in Table I. Out of the 11 studies, eight studies were case series (72.7%), two studies were case reports (18.2%), and one study was a cohort study (9.1%). Of note, nine studies reported follow-up durations, and the pooled mean follow-up duration was 18 months (range, 3-56.4 months). In addition, eight studies (72.7%) had a low risk of bias, while three studies (27.3%) had a moderate risk of bias (Table I).

As regards the patient characteristics (presented in Table II), it was found that among the 106 patients, 57 patients were male and 49 patients were female, with a mean age ranging from 23.5 to 67.1 years. Grade 3 AVMs were the most prevalent type of AVM, accounting for 35 cases (33.0%), and grade 2 AVMs accounted for 29 cases (27.4%), according to the preoperative analysis of the AVM and staging using the SMG. Preoperative imaging was performed in 99 patients (93.4%) and preoperative embolization was performed in 10 patients (9.4%). Only four studies (36.4%) reported the awake protocol employed, all of which used the asleep-awake-asleep technique.

 Intraoperative and post-operative findings

Among the common intraoperative guidance methods (Table II), cortical stimulation, cortical mapping and continuous ECoG were the most frequently used methods. As regards intraoperative complications (Table III), it is evident that no major complications hindered the operations, and the majority were associated with intracranial hemorrhage during the operation or speech arrest, which was resolved gradually during follow-up. The rates of intraoperative complications ranged from 0 to 75%, with a summary estimate rate of 21% (95% CI, 1 to 41%; I2 55%) (Fig. 2). Other post-operative complications (Table III) varied from mild facial weakness, aphasia and cranial nerve dysfunction to hemiplegia. The rates of post-operative complications ranged from 17 to 100% with a summary estimate rate of 33% (95% CI, 19 to 48%; I2 40%) (Fig. 3). These complications were resolved in follow-up in almost all cases described. The rates of follow-up complications ranged from 0 to 100%, with a summary estimate rate of 6% (95% CI, 1 to 10%; I2 30%) (Fig. 4).

 Resection status

The resection status of 74 patients (69.8%) was unreported (13,18). The rates of complete resection ranged from 60 to 100% with a summary estimate rate of 93% (95% CI, 82 to 100%; I2 0%) (Fig. 5). Cannestra et al (18) included 2 patients who had AVMs that were deemed unresectable at the time of AC (no resection attempts were made), and they were referred for RS. Gabarrós et al (16) had 1 patient who could not achieve a complete resection and was also referred for RS. Wang et al (10) had 1 patient that required repeat AC to achieve complete resection.

 Subgroup analysis

The rates of post-operative complications among SMG I-II ranged from 0 to 50%, with a summary estimate rate of 12% (95% CI, 2 to 22%; I2 0%) and among SMG III-V, these ranged from 0 to 100%, with a summary estimate rate of 31% (95% CI, 21 to 42%; I2 46%) (Fig. 6). There was significant heterogeneity found between different dosage subgroups (P-value=0.01). The rates of follow-up complications among SMG I-II ranged from 0 to 20%, with a summary estimate rate of 0% (95% CI, 0 to 4%; I2 0%) and among SMG III-V, these ranged from 0 to 100%, with a summary estimate rate of 9% (95% CI, 2 to 16%; I2 34%) (Fig. 7). There was significant heterogeneity found between different dosage subgroups (P-value=0.04).

 Discussion

The significance of identifying the eloquent areas during brain surgery has been well-established, and currently, AC is the gold standard for identifying these regions during glioma resection (19). The present systematic review aimed to highlight the importance of awake craniotomy during AVM surgery and to identify the subgroups of patients that would benefit from such an intervention. Previously published data suggest that motor or language function may shift to an adjacent gyrus or to a contralateral hemisphere (20,21). This shift could occur due to brain plasticity in the presence of long-standing lesions, such as AVMs (20,21). Monitoring brain function and preventing mistargeting during AVM surgery is critical for optimizing outcomes (12). The precise identification and localization of the language function appear to be feasible only with the patient is in an awake condition (20,21). Additionally, it allows surgeons to determine the extent of the resection that can be performed safely without causing functional loss (14). The evaluation of the outcome following AVM surgery was performed using the modified Rankin Scale (mRS) (22). This scale assesses functional independence on a seven-grade scale. Chan et al (11) and Gabarrós et al (16) reported that 5 patients (83%) and 3 patients (60%), respectively, exhibited an improvement in their functional outcome after AC in terms of mRS.

Among the patients who experienced worsening immediately post-operatively, the majority of the patients had improved and only 6 patients had neurological deficits since the surgery. The rate of neurological deficit is higher compared with cases where AC is used for glioma surgery (~5.5%) (23); however, it should be noted that AC is a standard procedure in glioma surgery, while it was recently utilized in AVM surgery. Additionally, the data used in the present study were derived from different institutions with different methods of IONM and a lower number of patients, which may have affected the outcome.

A total of four studies included in the present systematic review revealed that immediate postoperative neurological deficits can arise despite an uneventful intraoperative course (1,11,14,17). Cerebral edema, vascular injury, or damage to areas with significant inputs to eloquent regions can all result in deficits (24). Although the majority of patients with post-operative deficits recover, a subset may suffer from a permanent loss of function. The predictors of long-term functional outcome include age, location, SMG, pre-operative deficits, surgical complications and new post-operative deficits (25). High-SMG AVM tends to have a more complicated post-operative and follow-up course (26). This was also reflected in the present study, as the majority of the patients who did have permanent neurologic deficits had a SMG ≥III. High-grade AVMs are large and can extend deep into the white matter, making surgical resection difficult and posing a greater risk for the post-operative neurological deficit (27). Therefore, one of the subgroups that can potentially benefit from AC are patients with an SMG #x003C;III. Further studies are required to determine whether AC is beneficial and safe for AVMs with SMG ≥III compared to other treatment modalities. It is also worth noting that all the studies included in the present systematic review had no reported mortality (1,4,10-18).

The majority of the patients (55.6%) presented with either seizure or hemorrhage, highlighting that AC was performed in individuals with ruptured AVM. This could target the second subgroup that can benefit from AC: Individuals with ruptured AVM (3,11). A previous randomized trial demonstrated that medical management was superior to interventional management (neurosurgical, radiosurgical or endovascular procedures) for unruptured AVMs in the short term (28). Of note, that trial ended early due to significant mortality in the surgical group (28,29). AC could potentially facilitate safer resection, and a new trial could be conducted using AC in the armamentarium for the surgical treatment of AVMs.

Currently, to the best of our knowledge, there are no publications available in the literature for AVM that directly compare AC with other treatment modalities. Extrapolating data from brain tumor resection surgery, AC is said to be economically advantageous from a cost and resource perspective due to the reduced need for post-operative intensive care and shorter hospital stays (23,30). It is important to acknowledge that there are substantial risks not to be underestimated when resecting AVM with AC. The main concerns are loss of airway patency, significant or unexpected hemorrhage, and hemodynamic instability (16). Mild hypoxemia can impair brain relaxation and surgical exposure (16). Controlling the airway could be challenging, particularly in a patient with rigid pin fixation (16). Other concerns include patient movement, which might jeopardize delicate microsurgical maneuvers and patient discomfort or fatigue during long procedures (4). It should be noted that the success of AC is largely dependent on anesthetic experience and patient cooperation (4). In the present systematic review, the patients in the included studies who had airway difficulties or were unable to co-operate received immediate anesthetic management and/or oxygen supplementation, aiding procedure completion. Sleep apnea was a prevalent risk factor among patients who encountered airway difficulties, which may have contributed to the airway obstruction experienced during AC (10). However, this was managed without the need for general anesthesia and subsided after inserting bilateral nasal airways (10). Of note, 1 patient experienced arterial desaturation during AC that was responsive to oxygenation via a standard face mask and persistent encouragement for the patient to continue deep breathing (13). However, it is important to note that this complication arose due to onyx migration from arterial embolization (13). Intraoperative anesthetic management should include vigilance for sudden hemodynamic changes that might require massive fluid resuscitation and pharmacological manipulation of the circulation (16).

AC has also maximized the extent of surgical resection. Surgeons can resect with more confidence in non-eloquent areas and avoid eloquent regions (31). Increasing the extent of resection can provide potential benefits, such as symptom relief and neurological improvement (32,33). The majority of the patients in the studies included in the present systematic review achieved complete resection. These findings suggest that AC could potentially be a safe procedure that can be undertaken for AVM resection, particularly in eloquent areas and in patients with a SMG I-II. The findings presented herein are consistent with those of a previous systematic review that indicated that AC may allow for the precise excision of eloquent AVMs, while preserving crucial brain functions (34). Additionally, significant flow reduction in AVM does not protect against hemorrhage, and treatment must continue until it is obliterated completely (16). Thus, complete resection is vital in providing protection from re-hemorrhaging, and AC allows for this by providing an opportunity to achieve maximal resection safely. Other forms of management, such as RS, do not provide this immediate protection (35,36). Endovascular embolization also plays a role in the management of cerebral AVM in eloquent areas (36). It has been employed as an adjuvant to surgery in the management of cerebral AVMs, particularly those >3 cm in size (10,37). However, endovascular embolization does carry specific risks. In the case report by Tolly et al (13), the patient first underwent onyx embolization followed by AC, and it was found that the patient later developed hypoxemia intraoperatively due to an onyx pulmonary artery embolism. Other complications of AVM embolization include intraoperative or post-operative hemorrhage, cerebral ischemia, transient or permanent neurologic deficit and mortality (38-40).

The limitations of the present systematic review include the small population size, limited data concerning follow-up, and marked conceptual heterogeneity among the included studies. This reduced the value of the interpretation of the statistical analysis conducted. The present systematic review has also highlighted the low number of studies currently available and the absence of studies directly comparing AC with asleep surgery (and other treatment modalities) in the resection of AVM. Thus, further studies comparing other treatment modalities with asleep microsurgery are warranted in order to determine its overall benefits, including the neurological outcome, length of hospital stay and effectiveness of the technique. It should also be highlighted that approximately half of the studies included herein had a follow-up period of ≤6 months. Therefore, any shortcomings observed during these periods could either be enduring or part of an ongoing developmental process. As a result, long-term follow-up studies are required to assess the impact of AC on AVM resection.

In conclusion, to date at least to the best of our knowledge, this is the first meta-analysis assessing the role of AC in AVM resection. The results suggest that AC could potentially be a useful tool in resecting AVMs, specifically in patients with eloquence involvement, SMG #x003C;3, and unruptured AVMs. However, the present systematic review was based on studies with marked heterogeneity in patient selection, AVM location, resection techniques, surgical team, equipment, field strength and follow-up information. Farther well-designed observational studies with longer follow-up periods are thus required to provide integrated information regarding the safety and benefits of AC in patients with AVM.

 Acknowledgements

Not applicable.

 Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

 Authors' contributions

GF and KF conceptualized the study. VEG, GF, KF, SC, AH, AI, AY, CI, APA, GH, PS and NT analyzed the data, and wrote and prepared the draft of the manuscript. KF and GF provided critical revisions. All authors contributed to manuscript revision, and have read and approved the final version of the manuscript. GF and KF confirm the authenticity of all the raw data.

 Ethics approval and consent to participate

Not applicable.

 Patient consent for publication

Not applicable.

 Competing interests

Not applicable.

 References GhaffarWBAhsanKShafiqFEnamAAnaesthetic Management of Cerebral Arterio-venous malformation excision using Awake craniotomy: Initial experience of two casesJ Coll Physicians Surg Pak29 (Supp l)S74S7620193177974710.29271/jcpsp.2019.12.S74 FotakopoulosGBrotisAGFountasKNDilemmas in managing coexisting arteriovenous and cavernous malformations: Case reportBrain Circ8454920223537272610.4103/bc.bc_52_21 LawtonMTRutledgeWCKimHStapfCWhiteheadKJLiDYKringsTterBruggeKKondziolkaDMorganMKBrain arteriovenous malformationsNat Rev Dis Primers11500820152718838210.1038/nrdp.2015.8 AounRJNSatturMGKrishnaCGuptaAWelzMENanneyAD IIIKohtAHTateMCNoeKHSirvenJIAwake surgery for brain vascular malformations and moyamoya diseaseWorld Neurosurg10565967120172837724610.1016/j.wneu.2017.03.121 SolomonRAConnollyES JrArteriovenous malformations of the brainN Engl J Med3761859186620172848999210.1056/NEJMra1607407 SzelényiABelloLDuffauHFavaEFeiglGCGalandaMNeulohGSignorelliFSalaFWorkgroup for Intraoperative Management in Low-Grade Glioma Surgery within the European Low-Grade Glioma NetworkIntraoperative electrical stimulation in awake craniotomy: Methodological aspects of current practiceNeurosurg Focus28E720102012144210.3171/2009.12.FOCUS09237 PageMJMcKenzieJEBossuytPMBoutronIHoffmannTCMulrowCDShamseerLTetzlaffJMAklEABrennanSEThe PRISMA 2020 statement: An updated guideline for reporting systematic reviewsBMJ372n7120213378205710.1136/bmj.n71 MoolaSMunnZTufanaruCAromatarisESearsKSfetcuRCurrieMQureshiRMattisPLisyKMuPFChapter 7: Systematic reviews of etiology and risk. In: Aromataris E, Munn Z (eds.): JBI Manual for Evidence Synthesis. JBI, 2020. Available from https://synthesismanual.jbi.global. RStudio Team. RStudio: Integrated Development for R. [Internet]. RStudio, PBC, Boston, MA, 2023 [cited 2024 May 28]. Available from: http://www.rstudio.com/. WangATPillaiPGuranECarterHMinasianTLenartJVandseRAnesthetic management of awake craniotomy for resection of the language and motor cortex vascular malformationsWorld Neurosurg143e136e14820203273612910.1016/j.wneu.2020.07.050 ChanDYCChanDTMZhuCXLKanPKYNgAYHsiehYSAbrigoJPoonWSWongGKCAwake craniotomy for excision of arteriovenous malformations? A qualitative comparison study with stereotactic radiosurgeryJ Clin Neurosci51525620182953038410.1016/j.jocn.2018.02.019 ZhouQLiMYiLHeBLiXJiangYIntraoperative neuromonitoring during brain arteriovenous malformation microsurgeries and postoperative dysfunction: A retrospective follow-up studyMedicine (Baltimore)96e805420172895362310.1097/MD.0000000000008054 TollyBTKoskyJLKohtAHemmerLBA case report of onyx pulmonary arterial embolism contributing to hypoxemia during Awake craniotomy for arteriovenous malformation resectionA A Case Rep8868820172819586210.1213/XAA.0000000000000436 NimmannityaPTerakawaYKawakamiTTsuyuguchiNSatoHKawashimaTOhataKAwake craniotomy for cortical language mapping and resection of an arteriovenous malformation adjacent to eloquent areas under general anesthesia-A hybrid approachInterdisciplinary Neurosur21861882015 GambleAJSchafferSGNardiDJChalifDJKatzJDehdashtiARAwake craniotomy in arteriovenous malformation surgery: The usefulness of cortical and subcortical mapping of language function in selected patientsWorld Neurosurg841394140120152614281110.1016/j.wneu.2015.06.059 GabarrósAYoungWLMcDermottMWLawtonMTLanguage and motor mapping during resection of brain arteriovenous malformations: Indications, feasibility, and utilityNeurosurgery6874475220112131130010.1227/NEU.0b013e318207a9a7 YonekawaYImhofHGBjeljacMCurcicMKhanNThree cases of AVM at eloquent areas finally treated with conventional microsurgical method. In: Yonekawa Y, Keller E, Sakurai Y, Tsukahara T, (eds.): New Trends of Surgery for Stroke and its Perioperative Management. Vienna, Springer-Verlag, pp105-110, 2005. CannestraAFPouratianNForageJBookheimerSYMartinNATogaAWFunctional magnetic resonance imaging and optical imaging for dominant-hemisphere perisylvian arteriovenous malformationsNeurosurgery5580481420041545858810.1227/01.neu.0000137654.27826.71 IbrahimGMBernsteinMAwake craniotomy for supratentorial gliomas: Why, when and how?CNS Oncol1718320122505430110.2217/cns.12.1 LazarRMMarshallRSPile-SpellmanJDuongHCMohrJPYoungWLSolomonRLPereraGMDeLaPazRLInterhemispheric transfer of language in patients with left frontal cerebral arteriovenous malformationNeuropsychologia381325133220001086957510.1016/s0028-3932(00)00054-3 LazarRMMarshallRSPile-SpellmanJHacein-BeyLYoungWLMohrJPSteinBMAnterior translocation of language in patients with left cerebral arteriovenous malformationNeurology498028081997930534410.1212/wnl.49.3.802 PollockBEBrownRDUse of the modified Rankin scale to assess outcome after arteriovenous malformation radiosurgeryNeurology671630163420061710189510.1212/01.wnl.0000242738.60683.dd SerletisDBernsteinMProspective study of awake craniotomy used routinely and nonselectively for supratentorial tumorsJ Neurosurg1071620071763986510.3171/JNS-07/07/0001 BrownTShahAHBregyAShahNHThambuswamyMBarbariteEFuhrmanTKomotarRJAwake craniotomy for brain tumor resection: The rule rather than the exception?J Neurosurg Anesthesiol2524024720132360388510.1097/ANA.0b013e318290c230 GulatiSJakolaASNerlandUSWeberCSolheimOThe risk of getting worse: Surgically acquired deficits, perioperative complications, and functional outcomes after primary resection of glioblastomaWorld Neurosurg7657257920112225150610.1016/j.wneu.2011.06.014 ChowdhuryTZeilerFASinghGPHailuALoewenHSchallerBCappellaniRBWestMThe Role of intraoperative MRI in awake neurosurgical procedures: A systematic reviewFront Oncol843420183036410310.3389/fonc.2018.00434 DerdeynCPZipfelGJAlbuquerqueFCCookeDLFeldmannESheehanJPTornerJCAmerican Heart Association Stroke CouncilManagement of brain Arteriovenous malformations: A scientific statement for healthcare professionals from the American Heart Association/American Stroke AssociationStroke48e200e22420172864235210.1161/STR.0000000000000134 MohrJPParidesMKStapfCMoqueteEMoyCSOverbeyJRAl-Shahi SalmanRVicautEYoungWLHoudartEMedical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): A multicentre, non-blinded, randomised trialLancet38361462120142426810510.1016/S0140-6736(13)62302-8 MagroEGentricJCDarsautTEZieglerDMsi BojanowskiMWRaymondJResponses to ARUBA: A systematic review and critical analysis for the design of future arteriovenous malformation trialsJ Neurosurg12648649420172712858410.3171/2015.6.JNS15619 ZhangKGelbAWAwake craniotomy: Indications, benefits, and techniquesColombian J Anesthesiol4646512018 SackoOLauwers-CancesVBraugeDSesayMBrennerARouxFEAwake craniotomy vs surgery under general anesthesia for resection of supratentorial lesionsNeurosurgery681192119920112127392310.1227/NEU.0b013e31820c02a3 EnglotDJBergerMSBarbaroNMChangEFFactors associated with seizure freedom in the surgical resection of glioneuronal tumorsEpilepsia53515720122193318110.1111/j.1528-1167.2011.03269.x KimSSMcCutcheonIESukiDWeinbergJSSawayaRLangFFFersonDHeimbergerABDeMonteFPrabhuSSAwake craniotomy for brain tumors near eloquent cortex: Correlation of intraoperative cortical mapping with neurological outcomes in 309 consecutive patientsNeurosurgery6483684620091940414710.1227/01.NEU.0000342405.80881.81 RahmanRMajmundarNSanASanmugananthanPBerkeCLangSSTayebi MeybodiAGajjarAALiuJKSurgical outcomes of awake craniotomy for treatment of arteriovenous malformations in eloquent cortex: A systematic reviewWorld Neurosurgery175173020233700488510.1016/j.wneu.2023.03.109 FriedmanDIThe pseudotumor cerebri syndromeNeurol Clin3236339620143857525910.1016/j.ncl.2024.02.001 PollockBEFlickingerJCLunsfordLDBissonetteDJKondziolkaDFactors that predict the bleeding risk of cerebral arteriovenous malformationsStroke27161996855338210.1161/01.str.27.1.1 SenturkCEndovascular treatment of cerebral arteriovenous malformations. In: Gürer B, Kuru Bektaşoğlu P, (eds.): Vascular Malformations of the Central Nervous System. IntechOpen, 2020. JayaramanMVMarcellusMLHamiltonSDoHMCampbellDChangSDSteinbergGKMarksMPNeurologic complications of arteriovenous malformation embolization using liquid embolic agentsAJNR Am J Neuroradiol2924224620081797461310.3174/ajnr.A0793 SugiuKTokunagaKSasaharaWWatanabeKNishidaAOnoSNishioSDateIRüfenachtDAComplications of embolization for cerebral arteriovenous malformationsInterv Neuroradiol10 (Suppl 2)S59S6120042058725110.1177/15910199040100S212 LvXZhangYWangJSystematic review of transcatheter arterial embolization of AVM: Indications, bleeding complications, cure rate, and long-term bleeding riskNeurol India681285129220203334285410.4103/0028-3886.304101

Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flowchart (7) used for study selection.

A proportional metanalysis of the rates of intraoperative complications. The studies analyzed are listed. The numbers in the parentheses indicate the year of publication and the relevant reference number. CI, confidence interval.

A proportional metanalysis of the rates of post-operative complications. The studies analyzed are listed. The numbers in the parentheses indicate the year of publication and the relevant reference number. CI, confidence interval.

A proportional metanalysis of the rates of follow-up complications. The studies analyzed are listed. The numbers in the parentheses indicate the year of publication and the relevant reference number. CI, confidence interval.

A proportional metanalysis of the rates of complete resection. The studies analyzed are listed. The numbers in the parentheses indicate the year of publication and the relevant reference number. CI, confidence interval.

A subgroup proportional metanalysis of the rates of post-operative complications between SMG II and III-V. The studies analyzed are listed. The numbers in the parentheses indicate the year of publication and the relevant reference number. CI, confidence interval; SMG, Spetzler-Martin grade.

A subgroup proportional metanalysis of rates of follow-up complications between SMG II and III-V. The studies analyzed are listed. The numbers in the parentheses indicate the year of publication and the relevant reference number. CI, confidence interval; Spetzler-Martin grade.

Characteristics of the included studies.

Authors Year of publication Country Study design Population size for AC Mean follow-up duration (months) Risk of bias (Refs.)
Wang et al 2020 USA Case series 6 56.4 9/10 (10)
Ghaffar et al 2019 Pakistan Case series 2 NR 5/10 (1)
Chan et al 2018 China Case series 6 45 9/10 (11)
Zhou et al 2017 China Cohort study 73 12 5/11 (12)
Tolly et al 2017 USA Case report 1 3 8/8 (13)
Aoun et al 2017 USA Case series 2 9a 9/10 (4)
Nimmannitya et al 2015 Japan Case report 1 5 8/8 (14)
Gamble et al 2015 USA Case series 4 NR 9/10 (15)
Gabarrós et al 2011 USA Case series 5 25.9a 9/10 (16)
Yonekawa et al 2005 Switzerland Case series 1 3 5/10 (17)
Cannestra et al 2004 USA Case series 5 3 7/10 (18)

aCalculated from the data available in the studies. AC, awake craniotomy; NR, not reported.

Characteristics of the patients in the studies included in the present systematic review.

Authors, year of publication Population size for awake surgery (M/F) Mean age ± SDa (years) Hemorrhage or seizure at presentation (no. of patients) AVM location (no. of patients) Preoperative Embolization Preoperative imagingc SMG (no. of patients) Awake protocol IONM method (Refs.)
Wang et al, 2020 6 (5M/1F) 67.1±17.2 Seizure (n=3) Temporal (n=1), temporoparietal (n=1), frontal (n=2), frontoparietal (n=2) 2 6 Grade 2 (n=5), grade 3 (n=1) AAA Somatosensory-evoked potentials and DCS (language and motor functions). Continuous intracranial ECoG (10)
Ghaffar et al, 2019 2 (F) 23.5±3.5 Seizure (n=1) Frontal (n=1), temporoparietal (n=1) 1 2 Grade 1 (n=1), grade 3 (n=1) NR Cortical stimulation (verbal and motor response) (1)
Chan et al, 2018 6 (3M/3F) 31.2±13.7 Hemorrhage (n=5), seizure (n=1) Parietal (n=2), temporal (n=1), frontal (n=2), frontoparietal (n=1) NR NR Grade 2 (n=2), grade 3 (n=4) AAA Cortical mapping (naming, comprehension, calculation and motor functions) (11)
Zhou et al, 2017 73 (43M/30F) 34.9±17.5 Hemorrhage (n=41) Eloquence involvement (n=24) NR 73 Grade 1 (n=15), grade 2 (n=16), grade 3 (n=21), grade 4 (n=14), grade 5 (n=7) NR Neurophysiologic monitoring (brainstem auditory-evoked potential, electromyography, maximum expiratory pressure, somatosensory-evoked potential, visual-evoked potential, electroencephalography) (12)
Tolly et al, 2017 1 (M) 26b Seizure (n=1) Supratentorial (n=1) 1 1 Grade 2 (n=1) NR NR (13)
Aoun et al, 2017 2 (F) 46±10 Seizure (n=2) Temporal (n=1), parietal (n=1) NR 2 Grade 2 (n=2) AAA ECoG, intraoperative brain functional mapping, cortical mapping, and language/motor mapping (4)
Nimmannitya et al, 2015 1 (F) 38b Seizure (n=1) Frontal (n=1) 1 1 Grade 3 (n=1) AAA Cortical mapping (motor and language), motor and visual naming tasks (14)
Gamble et al, 2015 4 (1M/3F) 51.8±16.9 Hemorrhage (n=2), seizure (n=2) Fronto-opercular (n=2), temporal (n=2) NR 4 Grade 2 (n=2), grade 3 (n=2) NR Cortical mapping (language), subcortical stimulation (15)
Gabarrós et al, 2011 5 (2M/3F) 31±9.7 Hemorrhage (n=2), seizure (n=3) Frontoparietal (n=1), frontal (n=1), temporal (n=3) 4 5 Grade 3 (n=4), grade 4 (n=1) NR ECoG, somatosensory evoked potentials, language and motor mapping (16)
Yonekawa et al, 2005 1 (F) 35b NR Parietal (n=1) 1 NR Grade 4a NR NR (17)
Cannestra et al, 2004 5 (2M/3F) 34.8±10.8 NR Temporal (n=1), frontal (n=2), temporoparietal (n=2) NR 5 Grade 2 (n=1), grade 2 to 1 (n=1), grade 3 (n=1), grade 3 to 2 (n=1), grade 4 to 3 NR Language and motor mapping, continuous intracranial ECoG, intraoperative optical imaging of intrinsic signals (18)

aCalculated from the data available in the studies;

bpatient age (mean age could not be calculated as there was only 1 patient in the study);

cpreoperative imaging included MRI and/or angiogram. M, male; F, female; NR, not reported; SD, standard deviation; AAA, asleep-awake-asleep DCS, direct cortical stimulation; AVM, arteriovenous malformation; SMG, Spetzler-Martin grade; IONM, intraoperative neuromonitoring; ECoG, electrocorticography.

Intra-operative and post-operative findings.

Authors, year of publication Intraoperative complications (no. of patients) Complete resection Post-operative complications (no. of patients) Follow-up neurological deficits (no. of patients) Postoperative angiogram (Refs.)
Wang et al, 2020 Seizures (n=1), blood transfusion (n=1), anxiety and nausea (n=1) 6/6 Hemorrhage requiring transfusion and mild facial weakness, which recovered in 3 days (n=1); left-sided weakness; recovered completely in 7 days (n=1) Mild facial weakness, which recovered in 3 days (n=1); left-sided weakness; recovered completely in 7 days (n=1) No residual malformation after 1st surgery (n=5); no residual malformation after 2nd surgery (n=1) (10)
Ghaffar et al, 2019 None 2/2 Aphasia (n=1) Aphasia resolved completely in 48 h (n=1). No residual malformation (1)
Chan et al, 2018 None 5/6 Hemorrhage with neurological deficit (n=1) Improvement in functional outcome (n=5); no re-bleed or new neurological deficit (n=6) NR (11)
Zhou et al, 2017 NR NR Neurologic dysfunction (n=15) Hemiplegia, cranial nerve dysfunction, hemianopia, or aphasia (n=4) NR (12)
Tolly et al, 2017 Hypoxemiaa NR Onyx pulmonary arterial embolism (n=1)a No new complaints (n=1) NR (13)
Aoun et al, 2017 Seizure (n=1) 2/2 Transient left facial droop and arm twitching (n=1) No seizures, normal neurologic examinations and no speech impediments (n=2) No residual malformation nor AV shunting (4)
Nimmannitya et al, 2015 None 1/1 Speech difficulty (n=1) Speech difficulty resolved (n=1); neuropsychological tests: No deterioration of cognitive or language functions (n=1) No residual malformation (14)
Gamble et al, 2015 Speech arrest (n=2); hemorrhage (n=1) 4/4 Dysphasia (n=1) Dysphasia resolved (n=1) No residual malformation (15)
Gabarrós et al, 2011) ICH (n=1); EDH (n=1) 4/5 Temporal seizure (n=1) Temporal seizure continued persisting; improvement in functional outcome (n=3) Residual malformation in one patient with incomplete resection (16)
Yonekawa et al, 2005 None 1/1 Right-side hemiparesis appearing after 48 h (n=1) Right side hemiparesis subsided almost completely (n=1) No residual malformation (17)
Cannestra et al, 2004 None (AVMs deemed unresectable, n=2)b 3/5 Word generation deficit at one month (n=2) Word generation deficit resolved (n=1) NR (18)

aComplications were related to a prior procedure performed and not directly to awake craniotomy;

bAVMs deemed unresectable during awake craniotomy and thus resection was not attempted. NR, not reported; MINORS, methodological index for nonrandomized studies; AVMs, arteriovenous malformations; AV, arteriovenous ICH, intracerebral hematoma; EDH, epidural hematoma.